Polygenic risk scores for LATE-neuropathologic change: Implications for clinical utility.

Jung-Min Pyun; Young Ho Park; Lincoln M P Shade; David W Fardo; SangYun Kim; Kwangsik Nho; Alzheimer's Disease Neuroimaging Initiative

doi:10.1002/alz.71824

SCHEDA SCIENTIFICA2026Altra ricerca

Polygenic risk scores for LATE-neuropathologic change: Implications for clinical utility.

Jung-Min Pyun, Young Ho Park, Lincoln M P Shade, David W Fardo, SangYun Kim, Kwangsik Nho, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Psicologia clinica Psicologia cognitiva

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansGenetic Risk ScoreFemalePositron-Emission TomographyMaleAgedExecutive FunctionAged, 80 and overAlzheimer DiseaseDisease ProgressionTDP-43 ProteinopathiesBrainCognitive DysfunctionNeuropsychological TestsLongitudinal Studiesamyloid positron emission tomography statusbiomarkercognitionlimbic‐predominant age‐related TDP‐43 encephalopathypolygenic risk score

Come citare questo studio

Jung-Min Pyun, Young Ho Park, Lincoln M P Shade, David W Fardo, SangYun Kim, Kwangsik Nho, Alzheimer's Disease Neuroimaging Initiative. (2026). Polygenic risk scores for LATE-neuropathologic change: Implications for clinical utility.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71824

Consulta la pubblicazione originale ↗